EMTEX
ActiveEMTEX has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €799k and a net result of €372k. Equity is shrinking by ~4.7% per year across the filed fiscal years. Its solvency ranks better than 52% of 212 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
86
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability98▲+11
Solvency75▲+9
Growth58▼-20
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €65k at 30 days acceptable
Liquidity ample (current ratio 2.05 against 1.64 in 2024; short-term debt: 32.1% and cash: 34.8% of total assets), but 50.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
49.8%
Return on assets
23.1%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-06-2026, 52 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
52 d early
2024
36 d early
2023
22 d early
2022
31 d early
2021
13 d early
2020
17 d early
2019
31 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€799k▼ 39.8%
2024 · €1.33M
2018: €1.29M
2019: €1.69M
2020: €2.07M
2021: €2.66M
2022: €2.76M
2023: €1.79M
2024: €1.33M
2018 → 2025
Total assets
€1.61M▼ 50.7%
2024 · €3.25M
2018: €1.91M
2019: €2.50M
2020: €2.89M
2021: €3.71M
2022: €3.97M
2023: €4.23M
2024: €3.25M
2018 → 2025
Net result
€372k▼ 20.5%
2024 · €468k
2018: €285k
2019: €397k
2020: €379k
2021: €597k
2022: €266k
2023: €700k
2024: €468k
2018 → 2025
Working capital
€543k▼ 46.7%
2024 · €1.02M
2018: €1.24M
2019: €1.83M
2020: €2.09M
2021: €1.29M
2022: €1.32M
2023: €309k
2024: €1.02M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€2.66M-€2.76M▲ 3.5%€1.79M▼ 35.0%€1.33M▼ 25.9%€799k▼ 39.8%
Operating result€914k-€417k▼ 54.4%€956k▲ 129%€625k▼ 34.6%€510k▼ 18.5%
Net result€597k-€266k▼ 55.4%€700k▲ 163%€468k▼ 33.2%€372k▼ 20.5%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 18% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.61M
Fixed assets
€548k▼ 15.8%
Current assets
€1.06M▼ 59.4%
Equity and liabilities €1.61M
Equity
€799k▼ 39.8%
Debt
€806k▼ 58.2%
The debt ratio falls from 59.2% to 50.2%. Equity and debt are lower.
Key figures and ratios
EBITDA
€622k▼
2024 · €736k
Cash flow
€484k▼
2024 · €579k
Solvency
49.8%▲
2024 · 40.8%
Current ratio
2.05▲
2024 · 1.64
Quick ratio
2.05▲
2024 · 1.64
Debt / equity
1.01▼
2024 · 1.45
ROE
46.5%▲
2024 · 35.2%
ROA
23.1%▲
2024 · 14.4%
Interest coverage
22.60▲
2024 · 19.80
Debt
€806k▼
2024 · €1.93M
Debt ≤ 1 year
€515k▼
2024 · €1.59M
Debt > 1 year
€273k▼
2024 · €319k
Income taxes
€142k▼
2024 · €174k
Staff costs
€1.57M▲
2024 · €1.51M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€3.25M€1.61M▼
Fixed assets21/28€650k€548k▼
Intangible fixed assets21€3k€2k▼
Tangible fixed assets22/27€442k€340k▼
Land and buildings22€247k€220k▼
Plant, machinery and equipment23€58k€45k▼
Furniture and vehicles24€137k€75k▼
Other tangible fixed assets26€0-
Financial fixed assets28€206k€206k=
Current assets29/58€2.60M€1.06M▼
Amounts receivable after more than one year29€1.14M€0▼
Other amounts receivable291€1.14M€0▼
Amounts receivable within one year40/41€796k€491k▼
Trade receivables40€744k€480k▼
Other amounts receivable41€52k€11k▼
Current investments50/53€255€255=
Cash at bank and in hand54/58€666k€559k▼
Deferred charges and accrued income490/1€7k€7k▼
Equity and liabilities
Total equity and liabilities10/49€3.25M€1.61M▼
Equity10/15€1.33M€799k▼
Contributions10/11€19k€19k=
Reserves13€1.31M€781k▼
Distributable reserves133€1.31M€781k▼
Profit (loss) carried forward14€0€0=
Amounts payable17/49€1.93M€806k▼
Amounts payable after more than one year17€319k€273k▼
Financial debts170/4€319k€273k▼
Amounts payable within one year42/48€1.59M€515k▼
Current portion of amounts payable after more than one year42€80k€46k▼
Trade debts44€50k€29k▼
Suppliers440/4€50k€29k▼
Taxes, remuneration and social security45€380k€239k▼
Taxes450/3€231k€74k▼
Remuneration and social security454/9€149k€165k▲
Other amounts payable47/48€1.08M€200k▼
Accrued charges and deferred income492/3€20k€18k▼
Income statement
Code20242025
Non-recurring operating income76A€0-
Remuneration, social security and pensions62€1.51M€1.57M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€111k€112k▲
Other operating charges640/8€14k€10k▼
Non-recurring operating charges66A€7k€115▼
Gross operating margin9900€2.27M€2.20M▼
Operating profit (loss)9901€625k€510k▼
Financial income75/76B€53k€31k▼
Recurring financial income75€53k€31k▼
Financial charges65/66B€37k€28k▼
Recurring financial charges65€37k€28k▼
Profit (loss) for the period before taxes9903€641k€514k▼
Income taxes67/77€174k€142k▼
Profit (loss) for the period9904€468k€372k▼
Profit (loss) for the period to be appropriated9905€468k€372k▼
Appropriation of the result
Profit (loss) to be appropriated9906€468k€372k▼
Transfer from equity791/2€397k€901k▲
Transfer to equity691/2€68k€372k▲
To other reserves6921€68k€372k▲
Profit to be distributed694/7€797k€901k▲
Return on contributions (dividend)694€797k€901k▲
Social balance
Average headcount (FTE)908717.217.5▲
The notes to these accounts (25 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
09-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
25-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
09-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Highest result since 2018net €700k ▲163%
Operating result €956k, net result €700k, both a record.
30-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Weakest financial yearnet €266k ▼55.4%
Net result drops to €266k, the lowest in the series; recovery starts the following year.
18-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
14-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Equity above €2MEq €2.07M ▲22.5%
3 profitable years in a row build equity to €2.07M.
31-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 31 days late
2019
03-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
18-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
26-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Gillis-Waas · 1 establishment unit since 2008
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Hoogeindeken(GW) 89170 Sint-Gillis-WaasGround area
7,191 m²
Building footprint
1,986 m²
Volume, LiDAR
13,708 m³
Parcel 46020E0545/00F003, Flanders · tallest building 8.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
EMTEX BVBA
since 20082.185.321.215
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 46020E0545/00F003 | Flanders | 7,191 m² | 1 · 1,986 m² | 8.5 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 4 entries · 6,460 EUR awarded · 6,459 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 1,800 EUR | 1,800 EUR |
| 2024 | 1 | 0 EUR | 38 EUR |
| 2023 | 1 | 4,232 EUR | 4,584 EUR |
| 2022 | 1 | 428 EUR | 37 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Legal Entity Identifier
967600AUNKHH80REPC04
Similar companies · same sector, comparable size
PCBL Chemical Europe
BE 0800.743.611
Ath · Eq €799k
Normec Micro-Smedt
BE 0456.514.959
Herentals · Eq €808k
Inokura
BE 0424.658.872
Liège · Eq €808k
EUROFINS PHARMACEUTICAL PRODUCT TESTING BELGIUM
BE 0435.237.515
Brugge · Eq €816k
BIOPTEQ
BE 0877.753.196
Nandrin · Eq €816k
Of 1,178 companies in sector 72109 we hold annual accounts for 716. 467 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded06-12-2001
Fiscal year end31-12
Activities, NACEBEL
72109Other research and development on natural sciences
74855
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 24 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.